Covaxin had much lower adverse effects and overall favourable short-term safety profile in adolescents: Study

Credit: IndiaTimes- Published on May 16, 2024
Bharat Biotech’s indigenously developed Covid-19 vaccine Covaxin was overall found to have “much lower” AEFI (adverse effects following immunisation) rates in adolescents with a favourable short-term safety profile as compared to those reported with mRNA vaccines but adolescent females and those with a history of allergy...

You are here


💡 newsR Knowledge: Other News Mentions

You might like